BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 36073639)

  • 1. Coronary Artery Restenosis in Women by History of Preeclampsia.
    Lin A; Pehrson M; Sarno G; Fraser A; Rich-Edwards JW; Gonҫalves I; Pihlsgård M; Timpka S
    J Am Heart Assoc; 2022 Sep; 11(18):e026287. PubMed ID: 36073639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coronary artery restenosis and target lesion revascularisation in women by pregnancy history.
    Pehrson M; Edsfeldt A; Sarno G; Fraser A; Rich-Edwards JW; Goncalves I; Pihlsgård M; Timpka S
    Open Heart; 2023 Mar; 10(1):. PubMed ID: 36931658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proximal coronary artery intervention: stent thrombosis, restenosis and death.
    Calais F; Lagerqvist B; Leppert J; James SK; Fröbert O
    Int J Cardiol; 2013 Dec; 170(2):227-32. PubMed ID: 24211065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Second-generation versus first-generation drug-eluting stents for the treatment of patients with acute coronary syndromes and obstructive coronary artery disease.
    Machado C; Raposo L; Dores H; Leal S; Campante Teles R; de Araújo Gonçalves P; Mesquita Gabriel H; Almeida M; Mendes M
    Coron Artery Dis; 2014 May; 25(3):208-14. PubMed ID: 24419038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of previous drug-eluting stent restenosis in non-left main coronary artery lesions on long-term outcomes after left main coronary artery stenting: an observation from the AOI-LMCA registry.
    Higami H; Toyofuku M; Morimoto T; Ohya M; Fuku Y; Yamaji K; Muranishi H; Yamaji Y; Nishida K; Furukawa D; Tada T; Ko E; Ando K; Sakamoto H; Tamura T; Kawai K; Kadota K; Kimura T;
    Cardiovasc Interv Ther; 2018 Oct; 33(4):350-359. PubMed ID: 29052105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of coronary anatomy and stenting technique on long-term outcome after drug-eluting stent implantation for unprotected left main coronary artery disease.
    Tiroch K; Mehilli J; Byrne RA; Schulz S; Massberg S; Laugwitz KL; Vorpahl M; Seyfarth M; Kastrati A;
    JACC Cardiovasc Interv; 2014 Jan; 7(1):29-36. PubMed ID: 24332416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Outcome of Percutaneous Coronary Intervention for Significant Atherosclerotic Lesions in Segment Proximal to Myocardial Bridge at Left Anterior Descending Coronary Artery.
    Hao Z; Xinwei J; Ahmed Z; Huanjun P; Zhanqi W; Yanfei W; Chunhong C; Chan Z; Liqiang F
    Int Heart J; 2018 May; 59(3):467-473. PubMed ID: 29681571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meta-analysis of everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease: final 3-year results of the SPIRIT clinical trials program (Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions).
    Dangas GD; Serruys PW; Kereiakes DJ; Hermiller J; Rizvi A; Newman W; Sudhir K; Smith RS; Cao S; Theodoropoulos K; Cutlip DE; Lansky AJ; Stone GW
    JACC Cardiovasc Interv; 2013 Sep; 6(9):914-22. PubMed ID: 24050859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictor of in-stent restenosis in patients with drug-eluting stent (PRIDE)- a retrospective cohort study.
    Gupta PK; Balachander J
    Clin Investig Arterioscler; 2021; 33(4):184-194. PubMed ID: 33622608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognosis after maternal placental events and revascularization: PAMPER study.
    Ray JG; Booth GL; Alter DA; Vermeulen MJ
    Am J Obstet Gynecol; 2016 Jan; 214(1):106.e1-106.e14. PubMed ID: 26283454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-Term Efficacy and Safety of Paclitaxel-Eluting Balloon for the Treatment of Drug-Eluting Stent Restenosis: 3-Year Results of a Randomized Controlled Trial.
    Kufner S; Cassese S; Valeskini M; Neumann FJ; Schulz-Schüpke S; Hoppmann P; Fusaro M; Schunkert H; Laugwitz KL; Kastrati A; Byrne RA;
    JACC Cardiovasc Interv; 2015 Jun; 8(7):877-84. PubMed ID: 26003022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of major adverse cardiac events following elective stenting of large coronary arteries.
    Aghajani H; Alkamel A; Shafiee A; Jalali A; Nozari Y; Pourhosseini H; Kassaian SE; Salarifar M; Hajizeinali A; Amirzadegan A; Alidoosti M; Masoudkabir F; Nematipour E
    Indian Heart J; 2018; 70(1):20-23. PubMed ID: 29455782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Outcomes and Angiographic Results of Bailout Stenting for Guide Catheter-Induced Iatrogenic Coronary Artery Dissection - Impact of Stent Type.
    Amano H; Kubo S; Osakada K; Miura K; Ohya M; Shimada T; Murai R; Tada T; Tanaka H; Fuku Y; Goto T; Kadota K
    Circ J; 2020 Sep; 84(10):1746-1753. PubMed ID: 32893259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence, Clinical Presentation, and Predictors of Clinical Restenosis in Coronary Bioresorbable Scaffolds.
    Polimeni A; Weissner M; Schochlow K; Ullrich H; Indolfi C; Dijkstra J; Anadol R; Münzel T; Gori T
    JACC Cardiovasc Interv; 2017 Sep; 10(18):1819-1827. PubMed ID: 28935073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-Term Clinical Outcomes After Bioresorbable Vascular Scaffold Implantation for the Treatment of Coronary In-Stent Restenosis: A Multicenter Italian Experience.
    Moscarella E; Ielasi A; Granata F; Coscarelli S; Stabile E; Latib A; Cortese B; Tespili M; Tanaka A; Capozzolo C; Caliendo L; Colombo A; Varricchio A
    Circ Cardiovasc Interv; 2016 Apr; 9(4):e003148. PubMed ID: 27059683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors of in-stent restenosis among coronary artery disease patients with syphilis undergoing percutaneous coronary intervention: a retrospective study.
    Zhang L; Wang Y; Zhang Z; Liang H; Wu L; Ni L; Gao G; Yang D; Zhao H; Xiao J
    BMC Cardiovasc Disord; 2021 Sep; 21(1):438. PubMed ID: 34525967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Three-dimensional evaluation of the spatial morphology of stented coronary artery segments in relation to restenosis.
    Üveges Á; Jenei C; Kiss T; Szegedi Z; Tar B; Szabó GT; Czuriga D; Kőszegi Z
    Int J Cardiovasc Imaging; 2019 Oct; 35(10):1755-1763. PubMed ID: 31127455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Percutaneous Treatment and Outcomes of Small Coronary Vessels: A SCAAR Report.
    Silverio A; Buccheri S; Venetsanos D; Alfredsson J; Lagerqvist B; Persson J; Witt N; James S; Sarno G
    JACC Cardiovasc Interv; 2020 Apr; 13(7):793-804. PubMed ID: 32061601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of hyperuricemia on clinical outcomes after percutaneous coronary intervention for in-stent restenosis.
    Joo HJ; Jeong HS; Kook H; Lee SH; Park JH; Hong SJ; Yu CW; Lim DS
    BMC Cardiovasc Disord; 2018 Jun; 18(1):114. PubMed ID: 29890945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of very long-term clinical and angiographic outcomes of bare metal stent implants between patients with and without type 2 diabetes.
    Lu CH; Tsai ML; Chen CC; Hsieh MJ; Chang SH; Wang CY; Lee CH; Chen DY; Yang CH; Hsieh IC
    Prim Care Diabetes; 2017 Oct; 11(5):445-452. PubMed ID: 28576662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.